ARCHIVES

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

This article is from The Cancer Letter archive.

Vol. 16 No. 24 | June 15, 1990

Download PDF Visit The Full Archive

Related Articles

Senate Bill Matches 42.01 Billion Bush request For NCI, Sets Bypass Funding For Breast Cancer

September 18, 1992

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

August 1, 2014

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

December 27, 2013

HHS Inquiry Triggers Sloppy Stories On Gallo’s Laboratory

July 21, 1989

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

July 2, 2004